Crescita Reports Profitable 2019 Second Quarter Results

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc.

Crescita Awarded Cannabis Research License from Health Canada
Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics Loan
Crescita Signs Exclusive Distribution Agreement with FILLMED
Crescita Reports 2019 Third Quarter Results
U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®
Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals
Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City
United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.